6 research outputs found

    MRKAd5 HIV vaccine generated neutralizing antibodies to Ad5 capsid proteins more efficiently than to Ad5 fiber.

    No full text
    <p>The titers of Nab to Ad5, Ad5 F35, Ad35 and Ad35 F5 were determined in Ad5 seronegatives and Ad5 seropositives following vaccinations. The minimum detectable titer is at 1∶12 serum dilution and the maximum titer is at the end point dilution to achieve 90% neutralization of the vector. The development of Nab in baseline seronegatives (<b>A</b>) or seropositives (<b>B</b>) at 4 weeks after each vaccination was also shown. <b>A</b> (lower panel) and <b>B</b> (lower panel) show the Nab targets in these sera, excluding sera samples with high anti-Ad35 Nab titers which confound the categorization of the Nab target. (<b>C</b>) Direct comparison of the titer of Nabs to Ad5, or Ad5 capsid, or Ad5 fiber between baseline seronegatives and seropositives. Day 0: pre-vaccination; Week 4: 4 weeks after the first vaccination; Week 8: 4 weeks after the second vaccination; Week 30: 4 weeks after the third vaccination.</p
    corecore